LG focuses on global premium TV market with OLED TV

Updated 07 September 2015
0

LG focuses on global premium TV market with OLED TV

LG Electronics introduces its latest OLED 4K TVs at IFA 2015.
Aimed to sell more than one LG OLED TV per minute, Brian Kwon, EVP and CEO of LG’s Home Entertainment Company, cited four overarching marketing directions designed to solidify LG’s leadership role in the home entertainment market.
It strategizes to lead the global OLED TV market with an expanded OLED TV lineup by conducting enhanced marketing campaigns to expand OLED TV’s market penetration, strengthening its dominant position in the smart TV platform business, and enhancing profitability in the audio-video product segment.
With the “world’s first high dynamic range (HDR)-enabled 4K OLED TV,” LG will incorporate HDR technology in more of its OLED TV lineup.
The company will invest in a variety of marketing campaigns to increase international sales of its OLED TVs with product introduction tours and OLED displays at major airports in the world. LG is confident that strong reviews of LG OLED TVs from product testing organizations and media outlets will drive more interest in consumers. One US publication recently named LG’s OLED TV as this year’s best TV and LG’s model 65EG9600 was recognized as the King of TV by electronics distributor Value Electronics.
LG will continue to expand its webOS platform with more smart TV content from partners such as Netflix and YouTube, movies from local content suppliers and a range of new applications. The company will kick off an HDR content streaming service for webOS 2.0-enabled smart TV users in partnership with Amazon and roll out its value pack upgrade for webOS 1.0 user, which includes free features available in webOS 2.0.
Deuk Soo Ahn, president of LG Electronics Saudi Arabia, said: “It is a good opportunity to showcase the OLED sophisticated technology at the largest consumer electronics events. This technology is perfectly suited for leading the new TV generations.”


Pharmaceutical giant Allergan to train KSU pharmacy students

Updated 23 April 2019
0

Pharmaceutical giant Allergan to train KSU pharmacy students

Global biopharmaceutical company Allergan has signed a memorandum of understanding (MoU) with King Saud University (KSU) that focuses on developing a robust student-exchange program by facilitating training opportunities for Saudi nationals.

The agreement was signed by Ramsey Morad, Allergan’s vice president for India, Middle East and Africa, and Dr. Aws Al-Shamsan, dean of the College of Pharmacy at the university. The MoU is in line with the Kingdom’s overall efforts to drive more cooperation levels between the public and private sectors, with the underlying objective to integrate Saudi nationals into various fields within the health-care sector.

Under the agreement, Allergan will provide training courses on an annual basis for students at the College of Pharmacy as well as programs to develop their scientific and medical knowledge and align them to international industry best practices. Students will be assessed according to set parameters, and the top performers will earn an internship opportunity with the company

In addition, Allergan will run courses for faculty members at the College of Pharmacy with a focus on leadership skills.

Morad said: “We have used practical methods to express our commitment toward the Kingdom and toward the realization of Vision 2030. We are placing a very high emphasis on developing the local capabilities of Saudi nationals within the health-care sector, and this partnership with a leading university in the region is one of the steps we are taking. Saudi Arabia is at the heart of our operations in the region, and this MoU represents a key milestone in our efforts to attract the young minds of tomorrow and integrate them as core members of our Allergan team.” 

Al-Shamsan said: “We are proud to partner with Allergan to implement internationally recognized knowledge-based programs for the development of our students. With this MoU, we are focusing on the enhancement and development of the pharmaceutical sector across the Kingdom. We are guided by the mission to provide students experiences to learn from international best practices and, at the same time, work toward the improvement of the quality of the pharmaceutical sector in the Kingdom.”

Allergan said it is committed to a wide range of programs with health-care professionals, patients and national entities across the Kingdom. The company’s investments through its joint venture, Allergan Saudi Arabia, include the development of medical training centers focused on training health-care professionals in medical aesthetics.